glp 1 drugs for rheumatoid arthritis Glucagon-like peptide and its receptor agonists the treatment of rheumatic diseases Targeting the GLP-1/GLP-1R axis to

[PubMed] [Google Scholar] 7.Heinrich G, Gros P, Lund PK, Bentley RC, Habener JF

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Methodology Primary Research: Interviews with endocrinologists, clinical pharmacologists, and pharmaceutical market experts

Do D, Lee T, Peasah SK, Good CB, Inneh A, Patel U

Prospective trials with standardized vestibular examinations would offer a complete definition of GLP-1RA effects on vestibular function, ideally involving objective vestibular testing, patient-reported outcome measures, and prolonged follow-up periods

Weight Loss Potential: Modest results, typically between 2 to 10 pounds